Program Director/Principal Investigator (Last, First, Middle): T o t O , R o b e r t D . PROJECT SUMMARY (See instmctions): The CTSA has had a major impact on the clinical and translational research (CTR) environment at UT Southwestern. Many new and highly successful programs in education and training, pilot grant awards, biomedical informatics (BMI), biostatistics, population research, community health sciences, and patient- centered outcomes research have been established. Concurrently, the CTSA stimulated UT Southwestern to invest heavily in CTR infrastructure by recruiting new clinical and translational researchers into leadership positions of major clinical departments, by creating a new research institute that focuses on stem cell biology and cancer and by greatly enhancing genomics, metabolomics, proteomics, bioinformatics, and systems biology. Two new, state-of-the art hospitals are under construction, to open in fall 2014, and they incorporate design elements that will support CTR. Our vision is to accelerate translation of new discoveries into clinical practice (T0-T4) by leveraging our scientific strengths. We will integrate and centralize our resources to work in an encouraging and collaborative research environment. Our three Specific Aims are to: 1) Enhance our Research Environment to Accelerate Translation of Discovery into Practice. We formed the Center for Translational Medicine (Center), directed by the CTSA PI, to serve as the new integrated home for our CTSA. The Center will coordinate and expand the clinical research enterprise while it educates clinical and translational researchers at every level. 2) Leverage Existinq and New Resources to Build on Four Innovative Programs in Translation including: a) Target Identification and Validation;b) Discovery in Humans;c) Intervention in Humans and d) Population Science and Community Engagement. 3) Share Knowledge and Discoverv. and Contribute to the Leadership of the National Consortium. We will share gains that are made in our programs in educational and translational research programs with the Texas Regional CTSA consortium and National CTSA Consortium. We will contribute to leadership in areas of translation including T0-T4 research, and discovery and commercialization of new drugs and devices. Our vision for accelerating CTR is well aligned with the new NCATS initiatives and takes full advantage of gains made in the previous funding. We will establish new and improved programs that will enable investigators to discover, translate and disseminate new knowledge that will improve the prevention, detection, diagnosis, and effective treatment of disease.

Public Health Relevance

Improving the health of our nation requires a concerted effort by medical scientists, health care providers and public health policymakers. This grant application will provide the crucial infrastructure necessary for medical scientists to discover and apply new diagnostics and therapeutics for the detection, prevention, detection, diagnosis and effective treatment of disease. The goal is to accelerate the movement of these new discoveries into clinical practice to improve our nation's health in a safe and effective manner.

National Institute of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
Linked Specialized Center Cooperative Agreement (UL1)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-PTM-C (S2))
Program Officer
Talbot, Bernard
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Khera, Rohan; Angraal, Suveen; Couch, Tyler et al. (2017) Adherence to Methodological Standards in Research Using the National Inpatient Sample. JAMA 318:2011-2018
Yavuz, Metin; Ersen, Ali; Hartos, Jessica et al. (2017) Plantar Shear Stress in Individuals With a History of Diabetic Foot Ulcer: An Emerging Predictive Marker for Foot Ulceration. Diabetes Care 40:e14-e15
Thu, Kelsie L; Papari-Zareei, Mahboubeh; Stastny, Victor et al. (2017) A comprehensively characterized cell line panel highly representative of clinical ovarian high-grade serous carcinomas. Oncotarget 8:50489-50499
Makris, Una E; Misra, Devyani; Yung, Raymond (2017) Gaps in Aging Research as it Applies to Rheumatologic Clinical Care. Clin Geriatr Med 33:119-133
Lou, Ying; Cao, Jing; Zhang, Song et al. (2017) Sample Size Calculations for Time-Averaged Difference of Longitudinal Binary Outcomes. Commun Stat Theory Methods 46:344-353
Zhang, Song; Cao, Jing; Ahn, Chul (2017) Inference and sample size calculation for clinical trials with incomplete observations of paired binary outcomes. Stat Med 36:581-591
Rahbar, Mohammad H; Dickerson, Aisha S; Ahn, Chul et al. (2017) Characteristics of Biostatistics, Epidemiology, and Research Design Programs in Institutions With Clinical and Translational Science Awards. Acad Med 92:229-236
Krouse, Rebecca Z; Sorkness, Christine A; Wildfire, Jeremy J et al. (2017) Minimally important differences and risk levels for the Composite Asthma Severity Index. J Allergy Clin Immunol 139:1052-1055
Esquivel, Ann; Busse, William W; Calatroni, Agustin et al. (2017) Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma. Am J Respir Crit Care Med 196:985-992
Suresh, Shruthy; Durakoglugil, Deniz; Zhou, Xiaorong et al. (2017) SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer. PLoS Genet 13:e1006650

Showing the most recent 10 out of 429 publications